Loading organizations...
Loading organizations...
RNAi drug research and development platform for siRNA therapies.
Bowang Pharmaceutical has raised $41.0M across 1 funding round.
Bowang Pharmaceutical has raised $41.0M in total across 1 funding round.
Bowang Pharmaceutical has raised $41.0M in total across 1 funding round.
Bowang Pharmaceutical's investors include Zhang Yi, Trinity Innovation Fund.
Bowang Pharmaceutical has raised $41.0M across 1 funding round. Most recently, it raised $41.0M Series A in November 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2023 | $41.0M Series A | Zhang Yi, Trinity Innovation Fund |